US 6894026
Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders
expired A61KA61K31/395
Quick answer
US patent 6894026 (Long-acting oxytocin analogues for the treatment and prevention of breast cancer and psychiatric disorders) held by Atossa Healthcare, Inc. expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Atossa Healthcare, Inc.
- Grant date
- Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/395